In addition, lanthanum carbonate, in RCT of CKD stage 3b/4 patients without hyperphosphatemia, did not significantly affect on arterial stiffness, aortic calcification, and serum phosphorus, PTH, and FGF23 levels for 96 weeks [133]. Here, FGF23 is linked to hyperphosphatemia.